ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 668 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $384,569 | +15.1% | 4,931 | 0.0% | 0.15% | +14.3% |
Q1 2024 | $334,075 | +0.6% | 4,931 | 0.0% | 0.13% | -17.4% |
Q4 2023 | $332,103 | -0.5% | 4,931 | 0.0% | 0.16% | -6.9% |
Q3 2023 | $333,927 | +57.5% | 4,931 | +54.1% | 0.17% | +60.2% |
Q1 2022 | $212,000 | +48.3% | 3,200 | 0.0% | 0.11% | 0.0% |
Q1 2020 | $143,000 | – | 3,200 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |